Inspire Medical - רווח נקי למניה בארבעת הרבעונים האחרונים INSP

The annual percentage change in earnings per share (TTM) for Inspire Medical Systems (INSP) reflects yield dynamics, where the value 132.30 represents the current metric. Stable cash flow is secured by insurance company recognition, which prevents solution stagnation. Revenues are based on the sale of advanced neurostimulators for treating apnea. US-based production of unique systems creates a reliable alternative to mask therapy.

Inspire Medical Systems (INSP) maintains its leadership in the apnea therapy implant niche, yet expansion by medtech behemoths and weight-loss drugs creates significant risks. The net profit per share dynamics over the last 12 months, reflected through the EPS YoY TTM percentage change trend, allows for an objective assessment of capitalization rates and the timely identification of financial imbalances prior to the publication of quarterly reports.